1. Home
  2. EVO vs GB Comparison

EVO vs GB Comparison

Compare EVO & GB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • GB
  • Stock Information
  • Founded
  • EVO 1993
  • GB 1980
  • Country
  • EVO Germany
  • GB Switzerland
  • Employees
  • EVO N/A
  • GB N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • GB EDP Services
  • Sector
  • EVO Health Care
  • GB Technology
  • Exchange
  • EVO Nasdaq
  • GB Nasdaq
  • Market Cap
  • EVO 1.5B
  • GB 1.5B
  • IPO Year
  • EVO 2021
  • GB N/A
  • Fundamental
  • Price
  • EVO $4.11
  • GB $7.29
  • Analyst Decision
  • EVO Buy
  • GB Buy
  • Analyst Count
  • EVO 2
  • GB 1
  • Target Price
  • EVO $5.90
  • GB $6.00
  • AVG Volume (30 Days)
  • EVO 184.0K
  • GB 93.2K
  • Earning Date
  • EVO 11-06-2024
  • GB 02-21-2025
  • Dividend Yield
  • EVO N/A
  • GB N/A
  • EPS Growth
  • EVO N/A
  • GB 422.66
  • EPS
  • EVO N/A
  • GB 0.21
  • Revenue
  • EVO $866,665,179.00
  • GB $517,909,882.00
  • Revenue This Year
  • EVO $3.89
  • GB $20.57
  • Revenue Next Year
  • EVO $9.65
  • GB $11.33
  • P/E Ratio
  • EVO N/A
  • GB $35.28
  • Revenue Growth
  • EVO N/A
  • GB 21.84
  • 52 Week Low
  • EVO $2.85
  • GB $4.10
  • 52 Week High
  • EVO $8.39
  • GB $8.00
  • Technical
  • Relative Strength Index (RSI)
  • EVO 42.87
  • GB 57.26
  • Support Level
  • EVO $4.00
  • GB $7.48
  • Resistance Level
  • EVO $4.63
  • GB $7.80
  • Average True Range (ATR)
  • EVO 0.14
  • GB 0.40
  • MACD
  • EVO -0.04
  • GB -0.02
  • Stochastic Oscillator
  • EVO 16.88
  • GB 49.29

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About GB Global Blue Group Holding AG

Global Blue Group Holding AG offers a seamless shopping and payment journey for tourists and also provides a wide range of Added-Value Payment Solutions for all the stakeholders involved, including retailers and international shoppers. The company connect thousands of retailers, acquirers, and hotels with nearly 80 million consumers across more than 50 countries, in three industries: Tax Free Shopping, Payments and Post-Purchase solutions.

Share on Social Networks: